OTC · Biotechnology

Grey Matters Health Inc. (AGNPF) Stock

$0.25 -17.12% OTC: AGNPF Healthcare

Grey Matters Health, Inc. is a drug re-purposing company that investigates safe, already approved drugs, including naturally occurring compounds, for new disease applications, moving them into new human trials, developing new formulations and seeking new regulatory approvals in global markets.

Valuation

MetricValue
Price$0.25
Market Cap$869804
P/E Ratio-0.43
P/B Ratio0.29
P/S Ratio0.00
EPS (TTM)$-0.58
52-Week High$0.64
52-Week Low$0.22
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-66.67%
ROA-40.00%
ROCE-66.67%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio0.25

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-10.0M$-6.0M$-5.0M$-2.0M$-2.0M
Net Profit$-8.0M$-6.0M$-7.0M$-1.0M$-2.0M
EPS$-12.40$-8.70$-4.50$-0.25$-0.58
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$10.0M$8.0M$4.0M$4.0M$5.0M
Total Liabilities$1.0M$3.0M$3.0M$2.0M$2.0M
Cash$2.0M$1.0M$0$1.0M$0
Borrowings$0$0$0$0$0

Latest News

Grey Matters Health to open first NovaScan Neuroimaging Clinic in September Proactive · Aug 4, 2026 Grey Matters Announces September Opening of its First Brain Dedicated PET Neuroimaging Clinic in the U.S. GlobeNewswire · Aug 4, 2026 Grey Matters Health expands brain imaging services – ICYMI Proactive · Jul 11, 2026 Grey Matters receives first Brain PET scanner for flagship Florida Alzheimer's clinic Proactive · Jul 6, 2026 Grey Matters Health takes delivery of first brain-dedicated PET scanner for Florida clinic Proactive · Jul 6, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-8.0M$-3.0M$-3.0M$-3.0M$-1.0M
Investing Cash Flow$0$0$0$2.0M$0
Financing Cash Flow$2.0M$2.0M$0$0$0
Net Cash Flow$-4.0M$-1.0M$-1.0M$0$0
Free Cash Flow$-8.0M$-3.0M$-3.0M$-3.0M$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-0.74
FCF Yield-114.97%
Quick Ratio0.25
Interest Coverage—
Return 1Y-47.08%
Return 3Y-82.92%
Return 5Y—

Ownership

Insiders Held5.03%
Institutions Held17.64%
Institutions Float Held18.57%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Grey Matters Health Inc.

Grey Matters Health, Inc. is a drug re-purposing company that investigates safe, already approved drugs, including naturally occurring compounds, for new disease applications, moving them into new human trials, developing new formulations and seeking new regulatory approvals in global markets. It specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing. The company was founded on January 22, 2015 and is headquartered in Vancouver, Canada.

Grey Matters Health Inc. is headquartered in CA.

Grey Matters Health Inc. (AGNPF) stock trades at $0.25 with a market capitalization of $869804. The stock is valued at a price-to-earnings (P/E) ratio of -0.43, price-to-book of 0.29, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.22 and $0.64, and currently trades 60.9% below its 52-week high.

On profitability, Grey Matters Health Inc. generates a return on equity (ROE) of -66.67%, return on capital employed of -66.67%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.greymatters-health.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides